4//SEC Filing
Ignelzi Troy A. 4
Accession 0000950170-23-044413
CIK 0001771917other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 4:49 PM ET
Size
13.7 KB
Accession
0000950170-23-044413
Insider Transaction Report
Form 4
Ignelzi Troy A.
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-08-22$173.64/sh−80$13,891→ 31,907 total - Exercise/Conversion
Common Stock
2023-08-22$9.20/sh+1,500$13,800→ 31,987 total - Sale
Common Stock
2023-08-22$174.88/sh−855$149,522→ 31,052 total - Sale
Common Stock
2023-08-22$176.60/sh−60$10,596→ 30,487 total - Sale
Common Stock
2023-08-22$175.59/sh−505$88,673→ 30,547 total - Exercise/Conversion
Option (right to buy)
2023-08-22−1,500→ 93,226 totalExercise: $9.20Exp: 2029-03-21→ Common Stock (1,500 underlying)
Footnotes (6)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.31 to $174.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) through (5) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.32 to $175.31, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.32 to $176.30, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.59 to $176.61, inclusive.
- [F6]This option vested as to 25% of the shares on the first anniversary of the vesting commencement date of March 1, 2019, with additional vesting as to 12.5% of the shares underlying the option award on each six month period thereafter.
Documents
Issuer
Karuna Therapeutics, Inc.
CIK 0001771917
Entity typeother
Related Parties
1- filerCIK 0001579829
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 4:49 PM ET
- Size
- 13.7 KB